7,000,000 Shares* Common Stock, Par Value $0.001 Per Share Underwriting Agreement
EXHIBIT
1.1
EXECUTION COPY
U.S. CONCRETE, INC.
7,000,000 Shares*
Common Stock, Par Value $0.001 Per Share
Common Stock, Par Value $0.001 Per Share
Underwriting Agreement
To the Representatives
named in Schedule I
hereto of the Underwriters
named in Schedule II hereto
named in Schedule I
hereto of the Underwriters
named in Schedule II hereto
Ladies and Gentlemen:
U.S. Concrete, Inc., a corporation organized under the laws of the State of Delaware (the
“Company”), proposes to sell to the several underwriters named in Schedule II hereto (the
“Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of
shares of Common Stock, $0.001 par value (“Common Stock”), of the Company set forth in Schedule I
hereto (said shares to be issued and sold by the Company being hereinafter called the “Underwritten
Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to
the number of additional shares of Common Stock set forth in Schedule I hereto to cover
over-allotments (the “Option Securities” and, together with the Underwritten Securities, the
“Securities”). To the extent there are no additional Underwriters listed on Schedule I other than
you, the term Representatives as used herein shall mean you, as Underwriters, and the terms
Representatives and Underwriters shall mean either the singular or plural as the context requires.
Any reference herein to the Registration Statement, the Basic Prospectus, any Preliminary Final
Prospectus or the Final Prospectus shall be deemed to refer to and include the documents
incorporated by reference therein pursuant to Item 12 of Form S-3 which were filed under the
Exchange Act on or before the Effective Date of the Registration Statement or the issue date of the
Basic Prospectus, any Preliminary Final Prospectus or the Final Prospectus, as the case may be, and
any reference herein to the terms “amend,” “amendment” or “supplement” with respect to the
Registration Statement, the Basic Prospectus, any Preliminary Final Prospectus or the Final
Prospectus shall be deemed to refer to and include the filing of any document under the Exchange
Act after the Effective Date of the Registration Statement or the issue date of the Basic
Prospectus, any Preliminary Final Prospectus or the Final Prospectus, as the case may be, deemed to
be incorporated therein by reference. Certain capitalized terms used herein are defined in Section
19 hereof.
1. Representations and Warranties. The Company represents and warrants to, and agrees with, each Underwriter as set forth below in
this Section 1.
* Plus an option to purchase from the Company up to 1,050,000 additional Securities to cover over-allotments. |
(a) The Company meets the requirements for use of Form S-3 under the Act and has
prepared and filed with the Commission a registration statement (the file number of which is
set forth in Schedule I hereto) on Form S-3, including a related basic prospectus, for
registration under the Act of the offering and sale of the Securities. Such Registration
Statement, including any amendments thereto filed prior to the Execution Time, have become
effective. The Company may have filed with the Commission, as part of an amendment to the
Registration Statement or pursuant to Rule 424(b), one or more Preliminary Final
Prospectuses, each of which has previously been furnished to you. The Company will file
with the Commission a final prospectus supplement relating to the Securities in accordance
with Rule 424(b). As filed, such final prospectus supplement shall contain all information
required by the Act and the rules thereunder and, except to the extent the Representatives
shall agree in writing to a modification, shall be in all substantive respects in the form
furnished to you prior to the Execution Time or, to the extent not completed at the
Execution Time, shall contain only such specific additional information and other changes
(beyond that contained in the Basic Prospectus and any Preliminary Final Prospectus) as the
Company has advised you, prior to the Execution Time, will be included or made therein. The
Registration Statement, at the Execution Time, meets the requirements set forth in Rule
415(a)(1)(x).
It is understood that the form of prospectus to be used in connection with any offering and
sale of the Securities to Canadian Persons (as defined herein) shall have a Canadian
“wrap-around” (the “Canadian Offering Memorandum”). Insofar as they relate to offers or
sales of the Securities in Canada, all references herein to the Preliminary Final Prospectus
and the Final Prospectus shall include the Canadian Offering Memorandum.
(b) On the Effective Date, the Registration Statement did, and when the Final
Prospectus is first filed (if required) in accordance with Rule 424(b) and on the Closing
Date (as defined herein) and on any date on which Option Securities are purchased, if such
date is not the Closing Date (a “settlement date”), the Final Prospectus (and any supplement
thereto) will, comply in all material respects with the applicable requirements of the Act
and the Exchange Act and the respective rules thereunder; on the Effective Date and at the
Execution Time, the Registration Statement did not contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary
in order to make the statements therein not misleading; and on the date of the Final
Prospectus and on the Closing Date and any settlement date, the Final Prospectus (together
with any supplement thereto) will not include any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided, however,
that the Company makes no representations or warranties as to the information contained in
or omitted from the Registration Statement or the Final Prospectus (or any supplement
thereto) in reliance upon and in conformity with information furnished in writing to the
Company by or on behalf of any Underwriter through the Representatives specifically for
inclusion in the Registration Statement or the Final Prospectus (or any supplement thereto),
it being understood and agreed that the only such information furnished by or on behalf of any of the Underwriters consists of
the information described as such in Section 8 hereof.
2
(c) (i) The Disclosure Package and the price to the public, the number of Underwritten
Securities, the number of Option Securities and the underwriting discount on the cover page
of the Final Prospectus, when taken together as a whole, and (ii) each electronic roadshow
when taken together with the Disclosure Package, and the price to the public, the number of
Underwritten Securities, the number of Option Securities and the underwriting discount on
the cover page of the Final Prospectus, do not contain any untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The preceding
sentence does not apply to statements in or omissions from the Disclosure Package based upon
and in conformity with written information furnished to the Company by any Underwriter
through the Representatives specifically for use therein, it being understood and agreed
that the only such information furnished by or on behalf of any Underwriter consists of the
information described as such in Section 8 hereof.
(d) (i) At the earliest time after the filing of the Registration Statement that the
Company or another offering participant made a bona fide offer (within the meaning of Rule
164(h)(2)) of the Securities and (ii) as of the Execution Time (with such date being used as
the determination date for purposes of this clause (ii)), the Company was not and is not an
Ineligible Issuer (as defined in Rule 405), without taking account of any determination by
the Commission pursuant to Rule 405 that it is not necessary that the Company be considered
an Ineligible Issuer.
(e) Each Issuer Free Writing Prospectus does not include any information that conflicts
with the information contained in the Registration Statement, including any document
incorporated therein and any prospectus supplement deemed to be a part thereof that has not
been superseded or modified. The foregoing sentence does not apply to statements in or
omissions from the Disclosure Package based upon and in conformity with written information
furnished to the Company by any Underwriter through the Representatives specifically for use
therein, it being understood and agreed that the only such information furnished by or on
behalf of any Underwriter consists of the information described as such in Section 8 hereof.
(f) The Company is not, and after giving effect to the offering and sale of the
Securities and the application of the proceeds thereof as described in the Final Prospectus
will not be, an “investment company” as defined in the Investment Company Act.
(g) Since January 1, 2006, none of the Company, its subsidiaries or any of their
respective affiliates has paid or agreed to pay to any person any compensation for
soliciting another to purchase any securities of the Company (except as contemplated in this
Agreement).
(h) Since January 1, 2006, none of the Company, its subsidiaries or any of their
respective affiliates has taken, directly or indirectly, any action designed to or that
has constituted or that might reasonably be expected to cause or result, under the
Exchange Act or otherwise, in the stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Securities.
3
(i) Each of the Company and its subsidiaries has been duly incorporated or organized
and is validly existing as a corporation, limited liability company or limited partnership
in good standing under the laws of the jurisdiction in which it is chartered or organized
with full power and authority to own or lease, as the case may be, and to operate its
properties and conduct its business as described in the Disclosure Package and the Final
Prospectus, and is duly qualified to do business as a foreign corporation, limited liability
company or limited partnership, as applicable, and is in good standing under the laws of
each jurisdiction that requires such qualification, except where the failure to be so
qualified or in good standing would not reasonably be expected to have a material adverse
effect on the condition (financial or otherwise), prospects, earnings, business or
properties of the Company and its subsidiaries, taken as a whole, whether or not arising
from transactions in the ordinary course of business (a “Material Adverse Effect”). Schedule
IV attached hereto contains a complete and accurate list of each subsidiary of the Company.
(j) All the outstanding shares of capital stock or ownership interests of the Company
and its subsidiaries have been duly authorized and validly issued and are fully paid and
nonassessable and, except as otherwise set forth in the Disclosure Package and the Final
Prospectus, all outstanding shares of capital stock or ownership interests of the Company’s
subsidiaries are owned by the Company either directly or through wholly owned subsidiaries
free and clear of any security interest, claim, lien or encumbrance, except (i) any security
interest, claim, lien or encumbrance created by or under, or relating to, that certain
credit agreement, dated as of March 12, 2004, by and among the Company, Citicorp North
America, Inc., as administrative agent, and the several banks and other financial
institutions or entities from time to time parties thereto, including any notes, collateral
documents, letters of credit and documentation and guarantees and any appendices, exhibits,
schedules to any of the preceding and (ii) any liens with respect to the payment of taxes,
assessments or governmental charges in each case (A) that are not yet due or that are being
contested in good faith by appropriate proceedings and with respect to which adequate
reserves or other appropriate provisions are being maintained to the extent required by
generally accepted accounting principles or (B) in respect of which the aggregate liability
of all such entities does not exceed $250,000 at any time.
(k) There is no franchise, contract or other document of a character required to be
described in the Registration Statement or the Basic Prospectus, or to be filed as an
exhibit thereto, which is not described or filed as required; and the statements in the
Basic Prospectus under the heading “Description of Capital Stock” fairly summarize the
matters therein described.
(l) This Agreement has been duly authorized, executed and delivered by the Company; the
Company’s authorized equity capitalization is as set forth in the Disclosure Package and the
Final Prospectus; the capital stock of the Company conforms in all material respects to the
description thereof contained in the Final Prospectus; the outstanding shares of Common Stock have been duly and validly authorized and issued and
are fully paid and nonassessable; the Securities have been duly and validly authorized and,
when issued and delivered to and paid for by the Underwriters pursuant to this Agreement,
will be fully paid and nonassessable; the Securities are duly authorized
4
for trading, subject to official notice of issuance on the Nasdaq National Market; the certificates for
the Securities are in valid and sufficient form; the holders of outstanding shares of
capital stock of the Company are not entitled to preemptive or other rights to subscribe for
the Securities; and, except as set forth in the Final Prospectus, no options, warrants or
other rights to purchase, agreements or other obligations to issue, or rights to convert any
obligations into or exchange any securities for, shares of capital stock of or ownership
interests in the Company are outstanding.
(m) No consent, approval, authorization, filing with or order of any court or
governmental agency or body is required in connection with the transactions contemplated
herein, except such as have been obtained under the Act and such as may be required under
the federal and provincial securities laws of Canada and the blue sky laws of any
jurisdiction in connection with the purchase and distribution of the Securities by the
Underwriters in the manner contemplated herein and in the Final Prospectus.
(n) Neither the issue and sale of the Securities nor the consummation of any other of
the transactions herein contemplated nor the fulfillment of the terms hereof will conflict
with or result in a breach or violation of (i) the charter, by-laws or other organizational
documents of the Company or any of its subsidiaries, (ii) the terms of any indenture,
contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement,
obligation, condition, covenant or instrument to which the Company or any of its
subsidiaries is a party or bound or to which its or their property is subject or (iii) any
statute, law, rule, regulation, judgment, order or decree of any court, regulatory body,
administrative agency, governmental body, arbitrator or other authority having jurisdiction
over the Company or any of its subsidiaries or any of their respective properties, except in
the case of clauses (ii) and (iii) above, such breaches or violations or defaults that would
not have (x) a Material Adverse Effect or (y) a material adverse effect upon the
transactions contemplated herein or any Underwriter.
(o) The consolidated historical financial statements and schedules of the Company and
its consolidated subsidiaries included or incorporated by reference in the Preliminary Final
Prospectus, the Final Prospectus and the Registration Statement present fairly, in all
material respects, the financial condition, results of operations and cash flows of the
Company as of the dates and for the periods indicated, comply as to form with the applicable
accounting requirements of Regulation S-X of the Act and have been prepared in conformity
with generally accepted accounting principles applied on a consistent basis throughout the
periods involved (except as otherwise noted therein or in the notes thereto) and the
selected financial data set forth under the caption “Selected Consolidated Financial Data”
in the Preliminary Final Prospectus, the Final Prospectus and the Registration Statement
fairly present, in all material respects, on the basis stated in the Preliminary Final
Prospectus, the Final Prospectus and the Registration Statement, the information included
therein.
(p) No action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or any of its subsidiaries or
their respective properties is pending or, to the best knowledge of the Company, threatened
that (i) would reasonably be expected to have a material adverse
5
effect on the performance
by the Company and its subsidiaries of their obligations under this Agreement or the
consummation of any of the transactions contemplated hereby, or (ii) would reasonably be
expected to have a Material Adverse Effect, except as set forth in or contemplated in the
Disclosure Package and the Final Prospectus (exclusive of any supplement thereto).
(q) Each of the Company and its subsidiaries owns or leases, or has adequate rights to
use, all such properties as are necessary to the conduct of its respective operations as
presently conducted, except where the failure to so own, lease or have rights to use such
properties would not have a Material Adverse Effect.
(r) Neither the Company nor any of its subsidiaries is in violation or default of (i)
any provision of its charter, bylaws or other organizational documents, (ii) the terms of
any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or
other agreement, obligation, condition, covenant or instrument to which it is a party or
bound or to which its property is subject or (iii) any statute, law, rule, regulation,
judgment, order or decree applicable to the Company or any of its subsidiaries of any court,
regulatory body, administrative agency, governmental body, arbitrator or other authority
having jurisdiction over the Company or any of its subsidiaries or any of their respective
properties, as applicable, except in the case of clauses (ii) and (iii) above, such
violations or defaults that would not have (x) a Material Adverse Effect or (y) a material
adverse effect upon the transactions contemplated hereby.
(s) PricewaterhouseCoopers, LLP, who have certified certain financial statements of the
Company and its consolidated subsidiaries and delivered their report with respect to certain
audited consolidated financial statements included in the Final Prospectus, are independent
public accountants with respect to the Company within the meaning of the Act and the
applicable published rules and regulations thereunder.
(t) No labor problem or dispute with the employees of the Company or any of its
subsidiaries exists or, to the knowledge of the Company or its subsidiaries, is threatened
or imminent, and none of the Company or its subsidiaries is aware of any existing or
imminent labor disturbance by the employees of any of the Company’s or any of its
subsidiary’s principal suppliers, contractors or customers, except as would not have a
Material Adverse Effect and except as set forth in or contemplated in the Disclosure Package
and the Final Prospectus (exclusive of any supplement thereto).
(u) The Company and each of its subsidiaries are insured by recognized and, to the
knowledge of the Company and each of its subsidiaries, financially responsible insurers
against such losses and risks and in such amounts as are adequate and customary in the
businesses in which they are engaged; all material existing policies of insurance and
fidelity or surety bonds insuring the Company, its subsidiaries or any of their respective
businesses, assets, employees, officers and directors are in full force and
effect; the Company and its subsidiaries are in compliance with the terms of their
respective insurance policies, except where the failure to so comply would not have a
Material Adverse Effect; there are no material claims by the Company or any of its
subsidiaries under any such policy or instrument as to which any insurance company is
6
denying liability or defending under a reservation of rights clause; neither the Company
nor, to the knowledge of the Company (with such knowledge qualification only applying to the
Company’s subsidiaries acquired by the Company since January 1, 2004), any of its
subsidiaries has been refused any insurance coverage sought or applied for since January 1,
2004; and neither the Company nor any of its subsidiaries has any reason to believe that it
will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary or appropriate to
continue its business at a cost that would not have a Material Adverse Effect except as set
forth in or contemplated in the Disclosure Package and the Final Prospectus (exclusive of
any supplement thereto).
(v) No subsidiary of the Company is currently prohibited, directly or indirectly, from
paying any dividends, from making any other distribution on such subsidiary’s capital stock,
from repaying to the Company or any other subsidiary of the Company any loans or advances to
such subsidiary from the Company or any other subsidiary of the Company or from transferring
any of such subsidiary’s property or assets to the Company or any other subsidiary of the
Company, except as described in or contemplated in the Disclosure Package and the Final
Prospectus (exclusive of any supplement thereto) and except for any such prohibition as
would not have a Material Adverse Effect.
(w) The Company and each of its subsidiaries possess all licenses, certificates,
permits and other authorizations issued by the appropriate U.S. federal, state, local or
non-U.S. regulatory authorities necessary to conduct their respective businesses as now
operated by them, except where the failure to possess such licenses, certificates, permits
or other authorizations would not have a Material Adverse Effect, and neither the Company
nor any of its subsidiaries has received any notice of pending proceedings relating to the
revocation or modification of any such certificate, authorization or permit which, singly or
in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a
Material Adverse Effect, except as set forth in or contemplated in the Disclosure Package
and the Final Prospectus (exclusive of any supplement thereto).
(x) The Company maintains a system of disclosure controls and procedures sufficient to
(i) ensure that material information relating to the Company and its consolidated
subsidiaries is appropriately disclosed to the Company’s executive officers by others within
those entities, particularly during the period in which a consolidated financial report is
being prepared, (ii) evaluate the effectiveness of such disclosure controls and procedures
and present in such consolidated financial report its conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by such report
based on such evaluation, and (iii) disclose in such report any change in the Company’s
internal control over financial reporting on a consolidated basis that occurred during its
most recent fiscal quarter (or its fourth fiscal quarter in the case
of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting on a consolidated
basis.
(y) There is and has been no failure on the part of the Company and any of the
Company’s directors or officers, in their capacities as such, to comply in all material
7
respects with any applicable provision of the Sarbanes Oxley Act of 2002 and the rules and
regulations of the Commission promulgated in connection therewith, including Section 402
related to loans and Sections 302 and 906 related to certifications.
(z) The statistical and market-related data included in the Disclosure Package and the
Final Prospectus are based on or derived from sources that the Company and its subsidiaries
believe to be reliable and accurate.
(aa) The exhibits filed with the Company’s Form 10-K for the fiscal year ended December
31, 2004 and Forms 10-Q for the quarterly periods ended March 31, 2005, June 30, 2005 and
September 30, 2005 and Form 8-K dated December 16, 2005, respectively, are the only material
indentures, contracts, leases, mortgages, deeds of trust, note agreements, loan agreements
or other agreements, obligations, conditions, covenants or instruments (i) to which the
Company and its subsidiaries are a party or bound or to which their respective properties
are subject and (ii) which are required to be filed as exhibits pursuant to the Exchange
Act.
(bb) The only jurisdictions in which the Company and each of its subsidiaries are
required to be qualified to do business as a result of the conduct of their respective
operations, other than (i) the jurisdiction in which the Company and each subsidiary are
incorporated or formed or (ii) any jurisdiction in which the failure to be so qualified
would not have (x) a Material Adverse Effect or (y) a material adverse effect upon the
transactions contemplated herein or any Underwriter, are set forth opposite the Company’s
and such Subsidiary’s name on Schedule IV attached hereto.
(cc) No holders of securities of the Company have rights to the registration of such
securities under the Registration Statement that have not been effectively waived.
(dd) There are no transfer taxes or other similar fees or charges under U.S. federal
law or the laws of any state, or any political subdivision thereof, required to be paid in
connection with the execution and delivery of this Agreement or the issuance or sale by the
Company of the Securities.
(ee) The Company has filed all foreign, federal, state and local tax returns that are
required to be filed or has requested extensions thereof (except in any case in which the
failure so to file would not have a Material Adverse Effect, and except as set forth in or
contemplated in the Disclosure Package and the Final Prospectus (exclusive of any supplement
thereto)) and has paid or made adequate reserves for all taxes required to be paid by it and
any other assessment, fine or penalty levied against it, to the extent that any of the
foregoing is due and payable, except for any such assessment, fine or penalty that is
currently being contested in good faith or as would not have a Material Adverse Effect,
except as set forth in or contemplated in the Disclosure Package and the Final
Prospectus (exclusive of any supplement thereto).
(ff) The Company and its subsidiaries are (i) in compliance with any and all applicable
foreign, federal, state and local laws and regulations relating to the protection of human
health and safety, the environment or hazardous or toxic substances or wastes,
8
pollutants or contaminants (“Environmental Laws”), (ii) have received and are in compliance with all
permits, licenses or other approvals required of them under applicable Environmental Laws to
conduct their respective businesses and (iii) have not received notice of any actual or
potential liability under any Environmental Law, except where such non-compliance with
Environmental Laws, failure to receive or comply with required permits, licenses or other
approvals, or liability would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect, except as set forth in or contemplated in the Disclosure
Package and the Final Prospectus (exclusive of any supplement thereto). Except as set forth
in the Disclosure Package and the Final Prospectus, neither the Company nor any of the
subsidiaries has been named as a “potentially responsible party” under the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, as amended.
(gg) In the ordinary course of its business, the Company periodically reviews the
effect of Environmental Laws on the business, operations and properties of the Company and
its subsidiaries, in the course of which it identifies and evaluates associated costs and
liabilities (including, without limitation, any capital or operating expenditures required
for clean-up, closure of properties or compliance with Environmental Laws, or any permit,
license or approval, any related constraints on operating activities and any potential
liabilities to third parties). On the basis of such review, the Company has reasonably
concluded that such associated costs and liabilities would not, singly or in the aggregate,
reasonably be expected to have a Material Adverse Effect, except as set forth in or
contemplated in the Disclosure Package and the Final Prospectus (exclusive of any supplement
thereto).
(hh) All employee benefit plans established or maintained by the Company or any of its
subsidiaries comply in all material respects with all applicable requirements of the
Employee Retirement Income Security Act of 1974, as amended (“ERISA”); no such plan
established or maintained by the Company has incurred or assumed an “accumulated funding
deficiency” within the meaning of Section 302 of ERISA or has incurred or assumed any
material liability to the Pension Benefit Guaranty Corporation; and neither the Company nor
any of its subsidiaries has incurred or, based on current circumstances, would reasonably be
expected to incur any material liability under Title IV of ERISA, particularly including
withdrawal liability under Section 4201 of ERISA.
(ii) The Company, to the knowledge of the Company, is in compliance in all material
respects with all Marketplace Rules of the Nasdaq National Market applicable to the Company.
Any certificate signed by any officer of the Company and delivered to the Representatives or
counsel for the Underwriters in connection with the offering of the Securities shall be deemed a representation and warranty by the Company, as to matters covered thereby,
to each Underwriter.
2. Purchase and Sale. (a) Subject to the terms and conditions and in reliance upon
the representations and warranties herein set forth, the Company agrees to sell to each
Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the
9
Company, at the purchase price set forth in Schedule I hereto, the number of Underwritten
Securities set forth opposite such Underwriter’s name in Schedule II hereto.
(b) Subject to the terms and conditions and in reliance upon the representations and
warranties herein set forth, the Company hereby grants an option to the several Underwriters
to purchase, severally and not jointly, up to the number of Option Securities set forth in
Schedule I hereto at the same purchase price per share as the Underwriters shall pay for the
Underwritten Securities. Said option may be exercised only to cover over-allotments in the
sale of the Underwritten Securities by the Underwriters. Said option may be exercised in
whole or in part at any time on or before the 30th day after the date of the Final
Prospectus upon written or telegraphic notice by the Representatives to the Company setting
forth the number of Option Securities as to which the several Underwriters are exercising
the option and the settlement date. The number of Option Securities to be purchased by each
Underwriter shall be the same percentage of the total number of Option Securities to be
purchased by the several Underwriters as such Underwriter is purchasing of the Underwritten
Securities, subject to such adjustments as you in your absolute discretion shall make to
eliminate any fractional shares.
3. Delivery and Payment. Delivery of and payment for the Underwritten Securities and the
Option Securities (if the option provided for in Section 2(b) hereof shall have been exercised on
or before the third Business Day prior to the Closing Date) shall be made on the date and at the
time specified in Schedule I hereto or at such time on such later date not more than three Business
Days after the foregoing date as the Representatives shall designate, which date and time may be
postponed by agreement between the Representatives and the Company or as provided in Section 9
hereof (such date and time of delivery and payment for the Securities being herein called the
“Closing Date”). Delivery of the Securities shall be made to the Representatives for the
respective accounts of the several Underwriters against payment by the several Underwriters through
the Representatives of the purchase price thereof to or upon the order of the Company by wire
transfer payable in same-day funds to an account specified by the Company. Delivery of the
Underwritten Securities and the Option Securities shall be made through the facilities of The
Depository Trust Company unless the Representatives shall otherwise instruct.
If the option provided for in Section 2(b) hereof is exercised after the third Business Day
prior to the Closing Date, the Company will deliver the Option Securities (at the expense of the
Company) to the Representatives, at 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx, xx the date specified
by the Representatives (which shall be within three Business Days after exercise of said option) for the respective accounts of the several Underwriters,
against payment by the several Underwriters through the Representatives of the purchase price
thereof to or upon the order of the Company by wire transfer payable in same-day funds to an
account specified by the Company. If settlement for the Option Securities occurs after the Closing
Date, the Company will deliver to the Representatives on the settlement date for the Option
Securities, and the obligation of the Underwriters to purchase the Option Securities shall be
conditioned upon receipt of, supplemental opinions, certificates and letters confirming as of such
date the opinions, certificates and letters delivered on the Closing Date pursuant to Section 6
hereof.
10
4. Offering by Underwriters. It is understood that the several Underwriters propose to
offer the Securities for sale to the public as set forth in the Final Prospectus.
5. Agreements. The Company agrees with the several Underwriters that:
(a) Prior to the termination of the offering of the Securities, the Company will not
file any amendment of the Registration Statement or supplement (including the Final
Prospectus or any Preliminary Final Prospectus) to the Basic Prospectus or any Rule 462(b)
Registration Statement unless the Company has furnished you a copy for your review prior to
filing and will not file any such proposed amendment or supplement to which you reasonably
object. The Company will cause the Final Prospectus, properly completed, and any supplement
thereto to be filed in a form approved by the Representatives with the Commission pursuant
to the applicable paragraph of Rule 424(b) within the time period prescribed and will
provide evidence satisfactory to the Representatives of such timely filing. The Company
will promptly advise the Representatives when (i) the Final Prospectus, and any supplement
thereto, shall have been filed (if required) with the Commission pursuant to Rule 424(b) or
when any Rule 462(b) Registration Statement shall have been filed with the Commission, (ii)
when, prior to termination of the offering of the Securities, any amendment to the
Registration Statement shall have been filed or become effective, (iii) of any request by
the Commission or its staff for any amendment of the Registration Statement, or any Rule
462(b) Registration Statement, or for any supplement to the Final Prospectus or for any
additional information, (iv) of the issuance by the Commission of any stop order suspending
the effectiveness of the Registration Statement or of any notice that would prevent its use
or the institution or threatening of any proceeding for that purpose and (v) of the receipt
by the Company of any notification with respect to the suspension of the qualification of
the Securities for sale in any jurisdiction or the institution or threatening of any
proceeding for such purpose. The Company will use its best efforts to prevent the issuance
of any such stop order or the occurrence of any such suspension or prevention and, upon such
issuance, occurrence or prevention, to obtain as soon as possible the withdrawal of such
stop order or relief from such occurrence or prevention, including, if necessary, by filing
an amendment to the Registration Statement or a new registration statement and using its
best efforts to have such amendment or new registration statement declared effective as soon
as practicable.
(b) If there occurs an event or development as a result of which the Disclosure Package
would include an untrue statement of a material fact or would omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances then
prevailing, not misleading, the Company will notify promptly the Representatives so that any
use of the Disclosure Package may cease until it is amended or supplemented.
(c) If, at any time when a prospectus relating to the Securities is required to be
delivered under the Act (including in circumstances where such requirement may be satisfied
pursuant to Rule 172), any event occurs as a result of which the Final Prospectus as then
supplemented would include any untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein in the light of the
11
circumstances under which they were made not misleading, or if it shall be necessary to amend the
Registration Statement or supplement the Final Prospectus to comply with the Act or the
Exchange Act or the respective rules thereunder, including in connection with use or
delivery of the Final Prospectus, the Company promptly will (i) notify the Representatives
of such event, (ii) prepare and file with the Commission, subject to the second sentence of
paragraph (a) of this Section 5, an amendment or supplement which will correct such
statement or omission or effect such compliance, (iii) use its best efforts to have any
amendment to the Registration Statement declared effective as soon as practicable in order
to avoid any disruption in use of the Final Prospectus and (iv) supply any supplemented
Final Prospectus to you in such quantities as you may reasonably request.
(d) As soon as practicable, the Company will make generally available to its security
holders and to the Representatives an earnings statement or statements of the Company and
its subsidiaries which will satisfy the provisions of Section 11(a) of the Act and Rule 158.
(e) The Company will furnish to the Representatives and counsel for the Underwriters,
without charge, signed copies of the Registration Statement (including exhibits thereto) and
to each other Underwriter a copy of the Registration Statement (without exhibits thereto)
and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the
Act (including in circumstances where such requirement may be satisfied pursuant to Rule
172), as many copies of each Preliminary Final Prospectus, the Final Prospectus and each
Issuer Free Writing Prospectus and any supplement thereto as the Representatives may
reasonably request. The Company will pay the expenses of printing or other production of
all documents relating to the offering.
(f) The Company will arrange, if necessary, for the qualification of the Securities for
sale under the laws of such jurisdictions as the Representatives may designate and will
maintain such qualifications in effect so long as required for the distribution of the
Securities and will pay any fee of the National Association of Securities Dealers, Inc., in
connection with its review of the offering; provided that in no event shall the Company be
obligated to qualify to do business in any jurisdiction where it is not now so qualified or
to take any action that would subject it to the imposition of any tax or service of process
in suits, other than those arising out of the offering or sale of the Securities, in any jurisdiction where it is not now so subject. The Company and
its subsidiaries will promptly advise the Representatives of the receipt by the Company or
any of its subsidiaries of any notification with respect to the suspension of the
qualification of the Securities for sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose.
(g) The Company agrees that, unless it has obtained or will obtain the prior written
consent of the Representatives, and each Underwriter, severally and not jointly, agrees with
the Company that, unless it has obtained or will obtain, as the case may be, the prior
written consent of the Company, it has not made and will not make any offer relating to the
Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a “free writing prospectus” (as defined in Rule 405) required
12
to be filed by the Company with the Commission or retained by the Company under Rule 433; provided that the
prior written consent of the parties hereto shall be deemed to have been given in respect of
the Free Writing Prospectuses included in Schedule III hereto. Any such free writing
prospectus consented to by the Representatives or the Company is hereinafter referred to as
a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and will
treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing
Prospectus and (ii) it has complied and will comply, as the case may be, with the
requirements of Rules 164 and 433 applicable to any Permitted Free Writing Prospectus,
including in respect of timely filing with the Commission, legending and record keeping.
(h) Except as contemplated hereby, the Company will not, without the prior written
consent of Citigroup Global Markets Inc., offer, sell, contract to sell, pledge, or
otherwise dispose of (or enter into any transaction which is designed to, or might
reasonably be expected to, result in the disposition (whether by actual disposition or
effective economic disposition due to cash settlement or otherwise) by the Company or any
affiliate of the Company or any person in privity with the Company or any affiliate of the
Company) directly or indirectly, including the filing (or participation in the filing) of a
registration statement with the Commission in respect of, or establish or increase a put
equivalent position or liquidate or decrease a call equivalent position within the meaning
of Section 16 of the Exchange Act, any other shares of Common Stock or any securities
convertible into, or exercisable, or exchangeable for, shares of Common Stock, or publicly
announce an intention to effect any such transaction, until the Business Day set forth on
Schedule I hereto; provided, however, that the Company may issue and sell Common Stock
pursuant to any employee stock option plan, equity incentive plan, stock ownership plan or
dividend reinvestment plan of the Company in effect at the Execution Time and the Company
may issue Common Stock issuable upon the conversion of securities or the exercise of options
outstanding at the Execution Time.
(i) The Company will not take, directly or indirectly, any action designed to or that
would constitute or that might reasonably be expected to cause or result in, under the
Exchange Act or otherwise, stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Securities.
(j) The Company agrees to pay the costs and expenses relating to the following matters:
(i) the preparation, printing or reproduction and filing with the Commission of the
Registration Statement (including financial statements and exhibits thereto), each
Preliminary Final Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus,
and each amendment or supplement to any of them; (ii) the printing (or reproduction) and
delivery (including postage, air freight charges and charges for counting and packaging) of
such copies of the Registration Statement, each Preliminary Final Prospectus, the Final
Prospectus and each Issuer Free Writing Prospectus, and all amendments or supplements to any
of them, as may, in each case, be reasonably requested for use in connection with the
offering and sale of the Securities; (iii) the preparation, printing, authentication,
issuance and delivery of certificates for the Securities, including any stamp or transfer
taxes in connection with the original issuance and sale of the Securities; (iv) the printing
(or reproduction) and delivery of this
13
Agreement, any blue sky memorandum and all other agreements or documents printed (or reproduced) and delivered in connection with the
offering of the Securities; (v) the registration of the Securities under the Exchange Act
and the authorization for trading of the Securities on the Nasdaq National Market; (vi) any
registration or qualification of the Securities for offer and sale under the securities or
blue sky laws of the several states (including filing fees and the reasonable fees and
expenses of counsel for the Underwriters relating to such registration and qualification);
(vii) any filings required to be made with the National Association of Securities Dealers,
Inc. (including filing fees and the reasonable fees and expenses of counsel for the
Underwriters relating to such filings); (viii) the transportation and other expenses
incurred by or on behalf of Company representatives in connection with presentations to
prospective purchasers of the Securities (each of such presentations referred to herein as a
“roadshow”), provided, however, that for clarity (A) all expenses associated with the use of
any private aircraft in connection with the roadshow from January 23, 2006 through February
1, 2006, inclusive, shall be borne equally by the Company, on the one hand, and the
Underwriters, on the other hand and (B) all other costs and expenses associated with travel
and transportation in connection with the roadshow from January 23, 2006 through February 1,
2006, inclusive, shall be borne solely and entirely by the party which incurred such costs
and expenses; and (ix) the fees and expenses of the Company’s accountants and the fees and
expenses of counsel (including local and special counsel) for the Company (but not including
fees and expenses of counsel for the Underwriters, except as provided in clauses (vi) and
(vii) above); and (x) all other costs and expenses incident to the performance by the
Company of its obligations hereunder.
6. Conditions to the Obligations of the Underwriters. The obligations of the Underwriters
to purchase the Underwritten Securities and the Option Securities, as the case may be, shall be
subject to the accuracy of the representations and warranties on the part of the Company contained
herein as of the Execution Time, the Closing Date and any settlement date pursuant to Section 3
hereof (except to the extent such representations and warranties expressly relate to an earlier
date (in which case such representations and warranties shall be true and correct as of such
earlier date)), to the accuracy of the statements of the Company made in any certificates pursuant
to the provisions hereof, to the performance by the Company of its obligations hereunder and to the following additional
conditions:
(a) The Final Prospectus, and any supplement thereto, have been filed in the manner and
within the time period required by Rule 424(b); any material required to be filed by the
Company pursuant to Rule 433(d) under the Act shall have been filed with the Commission
within the applicable time periods prescribed for such filings by Rule 433; and no stop
order suspending the effectiveness of the Registration Statement or any notice objecting to
its use shall have been issued and no proceedings for that purpose shall have been
instituted or threatened.
(b) Xxxxx Xxxxx L.L.P., counsel for the Company, shall have furnished to the
Representatives its opinion, dated the Closing Date and addressed to the Representatives, to
the effect that:
14
(i) the Company has been duly incorporated and is validly existing as a corporation in
good standing under the laws of the State of Delaware, with full corporate power and
authority to own or lease, as the case may be, and to operate its properties and conduct its
business as described in the Disclosure Package and the Final Prospectus;
(ii) the Securities conform in all material respects to the description thereof
contained in the Disclosure Package and the Final Prospectus;
(iii) such counsel does not know of any pending or threatened legal or governmental
proceedings to which the Company or any of its subsidiaries or its or their property is
subject that, in such counsel’s judgment, are of a character required to be disclosed in the
Registration Statement which are not disclosed in the Disclosure Package and the Final
Prospectus, and there is no agreement, contract, indenture, lease or other instrument that,
in such counsel’s judgment, is of a character required to be described in the Registration
Statement or the Basic Prospectus, or to be filed as an exhibit to the Registration
Statement, which is not described or filed as required;
(iv) the statements in the Basic Prospectus under the heading “Description of Capital
Stock” fairly summarize the matters therein described;
(v) this Agreement has been duly authorized, executed and delivered by the Company;
(vi) no consent, approval, or authorization of, or filing with, any United States,
Texas, Delaware or New York court or governmental agency or body is required in connection
with the transactions contemplated herein, except such as have been obtained under the Act
and such as may be required under the blue sky laws of any jurisdiction (as to which such
counsel need express no opinion) in connection with the purchase and distribution of the
Securities by the Underwriters; and to the knowledge of such counsel, no order of any United
States, Texas, Delaware or New York court or governmental agency or body is required in
connection with the transactions contemplated herein, except such as may be required under
the Act or as may be required
under any blue sky laws of any jurisdiction in which the Securities are offered or sold
(as to which such counsel need express no opinion) in the manner contemplated in this
Agreement, in the Preliminary Prospectus and in the Final Prospectus and such other
approvals (specified in such opinion) as have been obtained;
(vii) neither the execution and delivery of this Agreement, the issuance and sale of
the Securities, nor the consummation of any other of the transactions herein contemplated,
nor the fulfillment of the terms hereof, will conflict with or result in a breach or
violation of (a) the charter or by-laws of the Company, (b) the terms of any indenture,
contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement,
obligation, condition, covenant or instrument to which the Company is a party or bound or to
which its property is subject and which has been filed as an exhibit to the Company’s Form
10-K filed with the Commission for the fiscal year ended December 31, 2004 and Forms 10-Q
for the quarterly periods ended March 31, 2005,
15
June 30, 2005 and September 30, 2005 and the
Form 8-K dated December 16, 2005, respectively, (c) any statute, law, rule or regulation
applicable to the Company of any governmental body, agency or court having jurisdiction over
the Company or any of its properties or (d) any judgment, order or decree, of which such
counsel is aware, applicable to the Company of any governmental body, agency or court having
jurisdiction over the Company or any of its properties, except in the case of clause (c) or
(d), for any such breach or violation as would not reasonably be expected to have a Material
Adverse Effect;
(viii) the Company is not and, after giving effect to the offering and sale of the
Securities and the application of the proceeds thereof as described in the Final Prospectus
(and any supplement thereto), will not be an “investment company” as defined in the
Investment Company Act, without taking account of any exemption arising out of the number of
holders of the Company’s securities; and
(ix) the Registration Statement has become effective under the Act; the Basic
Prospectus, the Preliminary Final Prospectus and the Final Prospectus, and any supplements
thereto, were filed with the Commission pursuant to Rule 424(b) in the manner and within the
time period required by Rule 424(b); and to the knowledge of such counsel, no stop order
suspending the effectiveness of the Registration Statement or any notice that would prevent
its use has been issued, no proceedings for that purpose have been instituted or threatened,
and the Registration Statement and the Final Prospectus (other than (a) the financial
statements, including the notes thereto and the auditors’ reports thereon, (b) the other
financial and accounting information contained or incorporated by reference therein or
omitted therefrom and (c) any statement or representation in any exhibits included or
incorporated by reference therein, as to which such counsel need express no opinion) when so
filed appeared on their face to have been responsive in all material respects to the
applicable requirements of the Act and the Exchange Act and the respective rules thereunder.
Such counsel shall state that they have participated in conferences with officers and other
representatives of the Company, representatives of the independent public accountants for the
Company, your representatives and your counsel at which conferences the contents of the
Registration Statement, the Final Prospectus, the Disclosure Package and related matters were
discussed, and although they did not independently verify the information in the Registration
Statement, the Final Prospectus and the Disclosure Package, and are not passing upon, and do not
assume any responsibility for, the accuracy, completeness or fairness of the statements contained
in the Registration Statement, the Final Prospectus and the Disclosure Package (except to the
extent set forth in paragraph (iv) above), such counsel shall advise you that, on the basis of the
foregoing (relying as to materiality to a large extent upon officers and other representatives of
the Company), no facts have come to such counsel’s attention which lead such counsel to believe (i)
that, on the Effective Date, at the time of filing of the Preliminary Final Prospectus with the
Commission and at the Execution Time, the Registration Statement (other than (a) the financial
statements, including the notes thereto and the auditors’ reports thereon, (b) the other financial
and accounting information contained or incorporated by reference therein or omitted therefrom and
(c) any statement or representation in any exhibits included or incorporated by reference therein,
as to which such counsel need express no opinion) contained any untrue
16
statement of a material fact
or omitted to state any material fact required to be stated therein or necessary to make the
statements therein not misleading, (ii) that the Final Prospectus (other than (a) the financial
statements, including the notes thereto and the auditors’ reports thereon and (b) the other
financial and accounting information contained or incorporated by reference therein or omitted
therefrom, as to which such counsel need express no opinion) as of its date and on the Closing
Date, included or includes any untrue statement of a material fact or omitted or omits to state a
material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading or (iii) that the Disclosure Package and the price to the
public, the number of Underwritten Securities, the number of Option Securities and the underwriting
discount on the cover page of the Final Prospectus (other than (a) the financial statements,
including the notes thereto and the auditors’ reports thereon and (b) the other financial and
accounting information contained or incorporated by reference therein or omitted therefrom, as to
which such counsel need express no opinion), when taken together as a whole, as of the Execution
Time contained any untrue statement of a material fact or omitted to state any material fact
necessary in order to make the statements therein, in the light of circumstances under which they
were made, not misleading.
In giving the foregoing opinions, such counsel may rely on certificates of representatives of
the Company and its subsidiaries and of public officials, as well as the representations and
warranties contained in this Agreement, with respect to the accuracy of the factual matters
contained therein, and may state that the opinions assume the genuineness of all signatures, the
conformity to authentic, original documents of all documents submitted to such counsel as certified
or photostatic copies and the authenticity of all documents submitted to such counsel as originals.
In giving the foregoing opinions, such counsel may further state that, except where otherwise
expressly stated, the opinions expressed are based on and are limited to the laws of the State of
Texas, the General Corporation Law of the State of Delaware and the laws of the State of New York,
in each case as currently in effect. References to the Final Prospectus in this Section 6(b) shall
also include any supplements thereto at the Closing Date.
(c) The Company shall have requested and caused Xxxxxx X. Xxxxx the Vice President,
General Counsel and Corporate Secretary of the Company to furnish to the
Representatives his opinion, dated the Closing Date and addressed to the
Representatives, to the effect that:
(i) each of the subsidiaries of the Company has been duly incorporated or organized and
is validly existing as a corporation, limited liability company or limited partnership in
good standing under the laws of the jurisdiction in which it is chartered or organized, with
full power and authority to own or lease, as the case may be, and to operate its properties
and conduct its business as described in the Disclosure Package and the Final Prospectus and
each of the Company and its subsidiaries is duly qualified to do business as a foreign
corporation, limited liability company or limited partnership and is in good standing under
the laws of the jurisdictions set forth opposite the Company’s and such subsidiary’s name on
Schedule IV attached hereto;
17
(ii) all the outstanding shares of capital stock or ownership interests of the Company
and each of the Company’s subsidiaries have been duly authorized and validly issued and are
fully paid and, in the case of shares of capital stock, nonassessable, and, except as
otherwise set forth in the Disclosure Package and the Final
Prospectus, all outstanding shares of capital stock or ownership interests of the Company’s subsidiaries are owned by
the Company either directly or through wholly owned subsidiaries free and clear of any
security interest, claim, lien or encumbrance, except (A) any security interest, claim, lien
or encumbrance created by or under, or relating to, that certain credit agreement, dated as
of March 12, 2004, by and among the Company, Citicorp North America, Inc., as administrative
agent, and the several banks and other financial institutions or entities from time to time
parties thereto, including any notes, collateral documents, letters of credit and
documentation and guarantees and any appendices, exhibits, schedules to any of the preceding
and (B) any liens with respect to the payment of taxes, assessments or governmental charges
in each case (1) that are not yet due or that are being contested in good faith by
appropriate proceedings and with respect to which adequate reserves or other appropriate
provisions are being maintained to the extent required by generally accepted accounting
principles or (2) in respect of which the aggregate liability of all such entities does not
exceed $250,000 at any time;
(iii) such counsel does not know of any pending or threatened legal or governmental
proceedings to which the Company or any of its subsidiaries or its or their property is
subject that, in such counsel’s judgment, are of a character required to be disclosed in the
Registration Statement which are not disclosed in the Disclosure Package and the Final
Prospectus, and there is no agreement, contract, indenture, lease or other instrument that,
in such counsel’s judgment, is of a character required to be described in the Registration
Statement or the Basic Prospectus, or to be filed as an exhibit to the Registration
Statement, which is not described or filed as required;
(iv) no holders of securities of the Company have rights to the registration of such
securities under the Registration Statement that have not been effectively waived;
(v) neither the execution and delivery of this Agreement, the issuance and sale of the
Securities, nor the consummation of any other of the transactions herein contemplated, nor
the fulfillment of the terms hereof, will conflict with or result in a breach or violation
of (a) the charter, by-laws or other organizational document of any of the subsidiaries of
the Company, (b) the terms of any indenture, contract, lease, mortgage, deed of trust, note
agreement, loan agreement or other agreement, obligation, condition, covenant or instrument
to which any of the subsidiaries of the Company is a party or bound or to which its property
is subject and which has been filed as an exhibit to the Company’s Form 10-K filed with the
Commission for the fiscal year ended December 31, 2004 and Forms 10-Q for the quarterly
periods ended March 31, 2005, June 30, 2005 and September 30, 2005 and the Form 8-K dated
December 16, 2005, respectively, (c) any statute, law, rule or regulation applicable to any
of the subsidiaries of the Company of any governmental body, agency or court having
jurisdiction over any of the subsidiaries of the Company or any of their properties or (d)
any judgment, order or decree, of which such counsel is aware, applicable to any of the
subsidiaries of the
18
Company of any governmental body, agency or court having jurisdiction
over any of the subsidiaries of the Company or any of their properties, except in the case
of clause (c) or (d), for any such breach or violation as would not reasonably be expected
to have a Material Adverse Effect;
(vi) the Registration Statement has become effective under the Act; the Basic
Prospectus, any Preliminary Final Prospectus and the Final Prospectus, and any supplements
thereto, were filed with the Commission pursuant to Rule 424(b) in the manner and within the
time period required by Rule 424(b) and to the knowledge of such counsel, no stop order
suspending the effectiveness of the Registration Statement or any notice that would prevent
its use has been issued, and no proceedings for that purpose have been instituted or
threatened.
Such counsel shall state that he has participated in conferences with other officers and
representatives of the Company, representatives of the independent public accountants for the
Company, your representatives and your counsel at which conferences the contents of the
Registration Statement, the Final Prospectus, the Disclosure Package and related matters were
discussed, and although he did not independently verify the information in the Registration
Statement, the Final Prospectus and the Disclosure Package, and is not passing upon, and does not
assume any responsibility for, the accuracy, completeness or fairness of the statements contained
in the Registration Statement, the Final Prospectus and the Disclosure Package, no facts have come
to such counsel’s attention which lead such counsel to believe that (i) on the Effective Date, at
the time of filing of the Preliminary Final Prospectus with the Commission and at the Execution
Time, the Registration Statement (other than (a) the financial statements, including the notes
thereto and the auditors’ reports thereon, (b) the other financial and accounting information
contained or incorporated by reference therein or omitted therefrom and (c) any statement or
representation in any exhibits included or incorporated by reference therein, as to which such
counsel need express no opinion) contained any untrue statement of a material fact or omitted to
state any material fact required to be stated therein or necessary to make the statements therein
not misleading, (ii) that the Final Prospectus (other than (a) the financial statements, including
the notes thereto and the auditors’ reports thereon and (b) the other financial and accounting
information contained or incorporated by reference therein or omitted
therefrom, as to which such counsel need express no opinion) as of its date and on the Closing
Date, included or includes any untrue statement of a material fact or omitted or omits to state a
material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading or (iii) that the Disclosure Package and the price to the
public, the number of Underwritten Securities, the number of Option Securities and the underwriting
discount on the cover page of the Final Prospectus (other than (a) the financial statements,
including the notes thereto and the auditors’ reports thereon and (b) the other financial and
accounting information contained or incorporated by reference therein or omitted therefrom, as to
which such counsel need express no opinion), when taken together as a whole, as of the Execution
Time contained any untrue statement of a material fact or omitted to state any material fact
necessary in order to make the statements therein, in the light of circumstances under which they
were made, not misleading.
In giving the foregoing opinions, such counsel may rely on certificates of other
representatives of the Company and its subsidiaries and of public officials, as well as the
19
representations and warranties contained in this Agreement, with respect to the accuracy of the
factual matters contained therein, and may state that the opinions assume the genuineness of all
signatures, the conformity to authentic, original documents of all documents submitted to such
counsel as certified or photostatic copies and the authenticity of all documents submitted to such
counsel as originals.
In giving the foregoing opinions, such counsel may further state that he is licensed to
practice law only in the State of Texas, that with respect to any jurisdiction other than Texas or
Delaware, such counsel assumes that the laws of such jurisdiction are the same as the laws of
Texas, and that such counsel’s opinion is provided in his capacity as an officer of the Company and
not in his individual capacity as an attorney. References to the Final Prospectus in this Section
6(c) include any amendment or supplement thereto at the Closing Date.
(d) The Representatives shall have received from Xxxxxx & Xxxxxx L.L.P., counsel for
the Underwriters, such opinion or opinions, dated the Closing Date and addressed to the
Representatives, with respect to the issuance and sale of the Securities, the Registration
Statement, the Disclosure Package, the Final Prospectus (together with any supplement
thereto) and other related matters as the Representatives may reasonably require, and the
Company shall have furnished to such counsel such documents as they request for the purpose
of enabling them to pass upon such matters.
(e) The Company shall have furnished to the Representatives a certificate of the
Company, signed by the Chairman of the Board or the President and the principal financial or
accounting officer of the Company, dated the Closing Date, to the effect that the signers of
such certificate have carefully examined the Registration Statement, the Final Prospectus,
the Disclosure Package and any supplements or amendments thereto and this Agreement and
that:
(i) the representations and warranties of the Company in this Agreement are
true and correct on and as of the Closing Date with the same effect as if made on
the Closing Date (except to the extent such representations and warranties expressly
relate to an earlier date (in which case such representations
and warranties shall be true and correct as of such earlier date)), and the
Company has complied with all the agreements and satisfied all the conditions on its
part to be performed or satisfied at or prior to the Closing Date;
(ii) no stop order suspending the effectiveness of the Registration Statement
or any notice that would prevent its use has been issued and no proceedings for that
purpose have been instituted or, to the Company’s knowledge, threatened; and
(iii) since the date of the most recent financial statements included or
incorporated by reference in the Final Prospectus (exclusive of any supplement
thereto), there has been no Material Adverse Effect, except as set forth in or
contemplated in the Disclosure Package and the Final Prospectus (exclusive of any
supplement thereto).
20
(f) At the Execution Time and at the Closing Date, the Company shall have requested and
caused PricewaterhouseCoopers LLP to furnish to the Representatives letters, dated
respectively as of the Execution Time and as of the Closing Date, in form and substance
reasonably satisfactory to the Representatives, (i) confirming that they are independent
accountants within the meaning of the Act and the Exchange Act and the applicable rules and
regulations thereunder, and (ii) stating, as of the date thereof (or, with respect to
matters involving changes or developments since the respective dates as of which specified
financial information is given in the Final Prospectus, as of a date not more than five days
prior to the date thereof), the conclusions and findings of such firm with respect to the
financial information and other matters ordinarily covered by accountants’ “comfort letters”
to underwriters in connection with registered public offerings. All references in this
Section 6(f) to the Final Prospectus include any supplement thereto at the date of the
letter.
(g) Subsequent to the Execution Time or, if earlier, the dates as of which information
is given in the Registration Statement (exclusive of any amendment thereof) and the Basic
Prospectus (exclusive of any supplement thereto), there shall not have been any Material
Adverse Effect, except as set forth in or contemplated in the Disclosure Package and the
Final Prospectus (exclusive of any supplement thereto), the effect of which, in any case
referred to above, is, in the sole judgment of the Representatives, so material and adverse
as to make it impractical or inadvisable to proceed with the offering or delivery of the
Securities as contemplated by the Registration Statement (exclusive of any amendment
thereof), the Disclosure Package and the Final Prospectus (exclusive of any supplement
thereto).
(h) Subsequent to the Execution Time, there shall not have been any decrease in the
rating of any of the Company’s debt securities by any “nationally recognized statistical
rating organization” (as defined for purposes of Rule 436(g) under the Act) or any notice
given of any intended or potential decrease in any such rating or of a possible change in
any such rating that does not indicate the direction of the possible change.
(i) Prior to the Closing Date, the Company shall have furnished to the Representatives
such further information, certificates and documents as the Representatives may reasonably
request.
(j) The Securities shall have been authorized for trading on the Nasdaq National
Market, and satisfactory evidence of such actions shall have been provided to the
Representatives.
(k) At the Execution Time, the Company shall have furnished to the Representatives a
letter substantially in the form of Exhibit A hereto from each officer and director of the
Company addressed to the Representatives; provided, that the letter from Xxxxxx X. Xxxxxx
shall provide that he may dispose of up to 250,000 shares of Common Stock, and the letter
from Xxxxxxx X. Xxxxxxxxx shall provide that he may dispose of up to 54,000 shares of Common
Stock, each at any time from and after the later of (i) the date that is two full trading
days after the Company publicly announces its earnings for the fourth quarter of 2005 and
(ii) February 27, 2006.
21
If any of the conditions specified in this Section 6 shall not have been fulfilled when and as
provided in this Agreement, or if any of the opinions and certificates mentioned above or elsewhere
in this Agreement shall not be reasonably satisfactory in form and substance to the Representatives
and counsel for the Underwriters, this Agreement and all obligations of the Underwriters hereunder
may be canceled at, or at any time prior to, the Closing Date by the Representatives. Notice of
such cancellation shall be given to the Company in writing or by telephone or facsimile confirmed
in writing.
The documents required to be delivered by this Section 6 shall be delivered at the office of
counsel for the Company, Xxxxx Xxxxx L.L.P., 000 Xxxxxxxxx, Xxxxxxx, Xxxxx 00000, on the Closing
Date.
7. Reimbursement of Underwriters’ Expenses. If the sale of the Securities provided for
herein is not consummated because any condition to the obligations of the Underwriters set forth in
Section 6 hereof is not satisfied, because of any termination pursuant to Section 10 hereof or
because of any refusal, inability or failure on the part of the Company to perform any agreement
herein or comply with any provision hereof other than by reason of a default by any of the
Underwriters, the Company will reimburse the Underwriters severally through Citigroup Global
Markets Inc. on demand for all out-of-pocket expenses (including reasonable fees and disbursements
of counsel) that shall have been incurred by them in connection with the proposed purchase and sale
of the Securities.
8. Indemnification and Contribution. (a) The Company agrees to indemnify and hold
harmless each Underwriter, the directors, officers, employees and agents of each Underwriter and
each person who controls any Underwriter within the meaning of either Section 15 of the Act or
Section 20 of the Exchange Act against any and all losses, claims, damages or liabilities, joint or
several, to which they or any of them may become subject under the Act, the Exchange Act or other
U.S. federal or state statutory law or regulation, at common law or otherwise, insofar as such
losses, claims, damages
or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement as
originally filed or in any amendment thereof or any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not
misleading or (ii) any untrue statement or alleged untrue statement of a material fact included in
the Basic Prospectus, any Preliminary Final Prospectus, the Final Prospectus, any Issuer Free
Writing Prospectus or in any amendment thereof or supplement thereto or any omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the
statements therein in light of the circumstances under which they were made not misleading, and
agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses
reasonably incurred by them in connection with investigating or defending any such loss, claim,
damage, liability or action; provided, however, that the Company will not be liable in any such
case to the extent that any such loss, claim, damage or liability arises out of or is based upon
any such untrue statement or alleged untrue statement or omission or alleged omission made therein
in reliance upon and in conformity with written information furnished to the Company by or on
behalf of any Underwriter through the Representatives specifically for inclusion therein. This
indemnity agreement will be in addition to any liability which the Company may otherwise have.
22
(b) Each Underwriter severally and not jointly agrees to indemnify and hold harmless
the Company, each of its directors and officers, and each person who controls the Company
within the meaning of either Section 15 of the Act or Section 20 of the Exchange Act, to the
same extent as the foregoing indemnity from the Company to each Underwriter, but only with
reference to written information relating to such Underwriter furnished to the Company by or
on behalf of such Underwriter specifically for inclusion in the documents referred to in the
foregoing indemnity. This indemnity agreement will be in addition to any liability which
any Underwriter may otherwise have. The Company acknowledges that (i) the statements set
forth in the last paragraph of the cover page regarding delivery of the Securities, (ii)
under the heading “Underwriting,” (A) the list of Underwriters and their respective
participation in the sale of the Securities, (B) the sentences related to concessions and
reallowances, (C) the paragraphs related to stabilization, syndicate covering transactions
and penalty bids and (iii) the Canadian Offering Memorandum (excluding any information
contained therein which was provided to any Underwriter by or on behalf of the Company)
contained in any Preliminary Final Prospectus and the Final Prospectus constitute the only
information furnished in writing by or on behalf of the several Underwriters for inclusion
in any Preliminary Final Prospectus or the Final Prospectus.
(c) Promptly after receipt by an indemnified party under this Section 8 of notice of
the commencement of any action, such indemnified party will, if a claim in respect thereof
is to be made against the indemnifying party under this Section 8, notify the indemnifying
party in writing of the commencement thereof; but the failure so to notify the indemnifying
party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to
the extent it did not otherwise learn of such action and such failure results in the
forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not,
in any event, relieve the indemnifying party from any obligations to any indemnified party
other than the indemnification obligation provided in paragraph (a) or (b) above. The
indemnifying party shall be entitled to appoint counsel
(including local counsel) of the indemnifying party’s choice at the indemnifying
party’s expense to represent the indemnified party in any action for which indemnification
is sought (in which case the indemnifying party shall not thereafter be responsible for the
fees and expenses of any separate counsel, other than local counsel if not appointed by the
indemnifying party, retained by the indemnified party or parties except as set forth below);
provided, however, that such counsel shall be reasonably satisfactory to the indemnified
party. Notwithstanding the indemnifying party’s election to appoint counsel (including
local counsel) to represent the indemnified party in an action, the indemnified party shall
have the right to employ separate counsel (including local counsel), and the indemnifying
party shall bear the reasonable fees, costs and expenses of such separate counsel if (i) the
use of counsel chosen by the indemnifying party to represent the indemnified party would
present such counsel with a conflict of interest, (ii) the actual or potential defendants
in, or targets of, any such action include both the indemnified party and the indemnifying
party and the indemnified party shall have reasonably concluded that there may be legal
defenses available to it that are different from or additional to those available to the
indemnifying party, (iii) the indemnifying party shall not have employed counsel reasonably
satisfactory to the indemnified party to represent the indemnified party within a reasonable
time after notice of the institution of such action or
23
(iv) the indemnifying party shall
authorize the indemnified party to employ separate counsel at the expense of the
indemnifying party; provided, however, that it is understood that the indemnifying party or
parties shall not, in respect of the legal expenses of any indemnified party in connection
with any proceeding or related proceedings in the same jurisdiction, be liable for the fees
and expenses of more than one separate firm (in addition to any local counsel) for all such
indemnified parties and that all such fees and expenses shall be reimbursed as they are
incurred. An indemnifying party will not, without the prior written consent of the
indemnified parties, settle or compromise or consent to the entry of any judgment with
respect to any pending or threatened claim, action, suit or proceeding in respect of which
indemnification or contribution may be sought hereunder (whether or not the indemnified
parties are actual or potential parties to such claim or action) unless such settlement,
compromise or consent includes an unconditional release of each indemnified party from all
liability arising out of such claim, action, suit or proceeding.
(d) In the event that the indemnity provided in paragraph (a), (b) or (c) of this
Section 8 is unavailable to or insufficient to hold harmless an indemnified party for any
reason, the Company and the Underwriters severally agree to contribute to the aggregate
losses, claims, damages and liabilities (including legal or other expenses reasonably
incurred in connection with investigating or defending same) (collectively “Losses”) to
which the Company and one or more of the Underwriters may be subject in such proportion as
is appropriate to reflect the relative benefits received by the Company on the one hand and
by the Underwriters on the other from the offering of the Securities; provided, however,
that in no case shall any Underwriter (except as may be provided in any agreement among
underwriters relating to the offering of the Securities) be responsible for any amount in
excess of the underwriting discount or commission applicable to the Securities purchased by
such Underwriter hereunder. If the allocation provided by the immediately preceding
sentence is unavailable for any reason, the Company and the Underwriters severally shall
contribute in such proportion as is
appropriate to reflect not only such relative benefits but also the relative fault of
the Company on the one hand and of the Underwriters on the other in connection with the
statements or omissions which resulted in such Losses as well as any other relevant
equitable considerations. Benefits received by the Company shall be deemed to be equal to
the total net proceeds from the offering (before deducting expenses) received by it, and
benefits received by the Underwriters shall be deemed to be equal to the total underwriting
discounts and commissions, in each case as set forth on the cover page of the Final
Prospectus. Relative fault shall be determined by reference to, among other things, whether
any untrue or any alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information provided by the Company on the one
hand or the Underwriters on the other, the intent of the parties and their relative
knowledge, access to information and opportunity to correct or prevent such untrue statement
or omission. The Company and the Underwriters agree that it would not be just and equitable
if contribution were determined by pro rata allocation or any other method of allocation
which does not take account of the equitable considerations referred to above.
Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to
contribution from any person who was not guilty of such
24
fraudulent misrepresentation. The
Underwriters’ obligations to contribute to this Section 8(d) are several in proportion to
their respective purchase obligations hereunder and not joint. For purposes of this Section
8, each person who controls an Underwriter within the meaning of either Section 15 of the
Act or Section 20 of the Exchange Act and each director, officer, employee, affiliate and
agent of an Underwriter shall have the same rights to contribution as such Underwriter, and
each person who controls the Company within the meaning of either Section 15 of the Act or
Section 20 of the Exchange Act and each officer and director of the Company shall have the
same rights to contribution as the Company, subject in each case to the applicable terms and
conditions of this paragraph (d).
9. Default by an Underwriter. If any one or more Underwriters shall fail to purchase and
pay for any of the Securities agreed to be purchased by such Underwriter or Underwriters hereunder
and such failure to purchase shall constitute a default in the performance of its or their
obligations under this Agreement, the remaining Underwriters shall be obligated severally to take
up and pay for (in the respective proportions which the amount of Securities set forth opposite
their names in Schedule II hereto bears to the aggregate amount of Securities set forth opposite
the names of all the remaining Underwriters) the Securities which the defaulting Underwriter or
Underwriters agreed but failed to purchase; provided, however, that in the event that the aggregate
amount of Securities which the defaulting Underwriter or Underwriters agreed but failed to purchase
shall exceed 10% of the aggregate amount of Securities set forth in Schedule II hereto, the
remaining Underwriters shall have the right to purchase all, but shall not be under any obligation
to purchase any, of the Securities, and if such nondefaulting Underwriters do not purchase all the
Securities, this Agreement will terminate without liability to any nondefaulting Underwriter or the
Company. In the event of a default by any Underwriter as set forth in this Section 9, the Closing
Date shall be postponed for such period, not exceeding five Business Days, as the Representatives
shall determine in order that the required changes in the Registration Statement and the Final
Prospectus or in any other documents or arrangements may be effected. Nothing contained in this
Agreement shall relieve any defaulting Underwriter of its liability, if any, to the Company and any
nondefaulting Underwriter for damages occasioned by its default hereunder.
10. Termination. This Agreement shall be subject to termination in the absolute discretion
of the Representatives, by notice given to the Company prior to delivery of and payment for the
Securities, if at any time prior to such time (i) trading in the Company’s Common Stock shall have
been suspended by the Commission or the Nasdaq National Market or trading in securities generally
on the New York Stock Exchange or the Nasdaq National Market shall have been suspended or limited
or minimum prices shall have been established on either such exchange or the Nasdaq National
Market, (ii) a banking moratorium shall have been declared either by U.S. federal or New York State
authorities or (iii) there shall have occurred any outbreak or escalation of hostilities,
declaration by the United States of a national emergency or war or other calamity or crisis the
effect of which on financial markets is such as to make it, in the sole judgment of the
Representatives, impractical or inadvisable to proceed with the offering or delivery of the
Securities as contemplated by the Final Prospectus (exclusive of any supplement thereto).
25
11. Indemnities to Survive. The respective agreements, indemnities and other covenants of
the Company or its officers and of the Underwriters set forth in or made pursuant to this Agreement
will remain in full force and effect, regardless of any investigation made by or on behalf of any
Underwriter or the Company or any of the indemnified persons referred to in Section 8 hereof, and
will survive delivery of and payment for the Securities. The provisions of Sections 7 and 8 hereof
shall survive the termination or cancellation of this Agreement.
12. Notices. All communications hereunder will be in writing and effective only on
receipt, and, if sent to the Representatives, will be mailed, delivered or telefaxed to the
Citigroup Global Markets Inc. General Counsel (fax no.: (000) 000-0000) and confirmed to the
General Counsel, Citigroup Global Markets Inc., at 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx, 00000,
Attention: General Counsel; or, if sent to the Company, will be mailed, delivered or telefaxed to
(000) 000-0000 and confirmed to it at 0000 Xxxxxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000, attention
of the Legal Department with a copy, which shall not constitute notice hereunder, to Xxxxx Xxxxx
L.L.P., attention: Xxx Xxxxx, 000 Xxxxxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000, telefax (000)
000-0000.
13. Successors. This Agreement will inure to the benefit of and be binding upon the
parties hereto and their respective successors and the officers, directors, employees, agents and
controlling persons referred to in Section 8 hereof, and no other person will have any right or
obligation hereunder.
14. No fiduciary duty. The Company hereby acknowledges that (a) the purchase and sale of the Securities pursuant to this
Agreement is an arm’s-length commercial transaction between the Company, on the one hand, and the
Underwriters and any affiliate through which it may be acting, on the other, (b) the Underwriters
are acting as principal and not as an agent or fiduciary of the Company and (c) the Company’s
engagement of the Underwriters in connection with the offering and the process leading up
to the offering is as independent contractors and not in any other capacity. Furthermore, the
Company agrees that it is solely responsible for making its own judgments in connection with the
offering (irrespective of whether any of the Underwriters has advised or is currently advising the
Company on related or other matters). The Company agrees that it will not claim that the
Underwriters have rendered advisory services of any nature or respect, or owe an agency, fiduciary
or similar duty to the Company, in connection with such transaction or the process leading thereto.
15. Integration. This Agreement supersedes all prior agreements and understandings (whether
written or oral) between the Company and the Underwriters, or any of them, with respect to the
subject matter hereof.
16. Applicable Law. This Agreement will be governed by and construed in accordance with
the laws of the State of New York applicable to contracts made and to be performed within the State
of New York. The parties hereto each hereby waive any right to trial by jury in any action,
proceeding or counterclaim arising out of or relating to this Agreement.
17. Counterparts. This Agreement may be signed in one or more counterparts, each of which
shall constitute an original and all of which together shall constitute one and the same agreement.
26
18. Headings. The section headings used herein are for convenience only and shall not
affect the construction hereof.
19. Definitions. The terms which follow, when used in this Agreement, shall have the
meanings indicated.
“Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations
of the Commission promulgated thereunder.
“Basic Prospectus” shall mean the prospectus referred to in paragraph 1(a) above
contained in the Registration Statement at the Effective Date.
“Business Day” shall mean any day other than a Saturday, a Sunday or a legal holiday or
a day on which banking institutions or trust companies are authorized or obligated by law to
close in the City of New York.
“Canadian Person” shall mean any person who is a national or resident of Canada, any
corporation, partnership or other entity created or organized in or under the laws of Canada
or of any political subdivision thereof, or any estate or trust the income of which is
subject to Canadian Federal income taxation, regardless of its source (other than any
non-Canadian branch of any Canadian Person), and shall include any Canadian branch of a
person other than a Canadian Person.
“Code” shall mean the Internal Revenue Code of 1986, as amended.
“Commission” shall mean the Securities and Exchange Commission.
“Disclosure Package” shall mean (i) the Basic Prospectus, as amended and supplemented
to the Execution Time, (ii) the Issuer Free Writing Prospectuses, if any, identified in
Schedule III hereto, and (iii) any other Free Writing Prospectus that the parties hereto
shall hereafter expressly agree in writing to treat as part of the Disclosure Package.
“Effective Date” shall mean each date and time that the Registration Statement, any
post-effective amendment or amendments thereto and any Rule 462(b) Registration Statement
became or become effective.
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission promulgated thereunder.
“Execution Time” shall mean the date and time that this Agreement is executed and
delivered by the parties hereto.
“Final Prospectus” shall mean the prospectus supplement relating to the Securities that
was first filed pursuant to Rule 424(b) after the Execution Time, together with the Basic
Prospectus.
27
“Free Writing Prospectus” shall mean a free writing prospectus, as defined in Rule 405.
“Issuer Free Writing Prospectus” shall mean an issuer free writing prospectus, as
defined in Rule 433.
“Preliminary Final Prospectus” shall mean any preliminary prospectus supplement to the
Basic Prospectus which describes the Securities and the offering thereof and is used prior
to filing of the Final Prospectus, together with the Basic Prospectus.
“Registration Statement” shall mean the registration statement referred to in paragraph
1(a) above, including (i) all documents filed as a part thereof or incorporated
or deemed to be incorporated by reference therein, (ii) any information contained or
incorporated by reference in any prospectus supplement relating to the Securities that is
filed with the Commission pursuant to Rule 424(b) and deemed part of such registration
statement pursuant to Rule 430B, as amended at the Execution Time and, in the event any
post-effective amendment thereto or any Rule 462(b) Registration Statement becomes effective
prior to the Closing Date, shall also mean such registration statement as so amended or such
Rule 462(b) Registration Statement, as the case may be.
“Rule 158”, “Rule 163”, “Rule 164”, “Rule 172”, “Rule 405”, “Rule 415”, “Rule 424”,
“Rule 430B”, and “Rule 433” and “Rule 462” refer to such rules under the Act.
“Rule 462(b) Registration Statement” shall mean a registration statement and any
amendments thereto filed pursuant to Rule 462(b) relating to the offering covered by the
registration statement referred to in Section 1(a) hereof.
20. Canada. Each of the Underwriters hereby agrees, severally and not jointly, that
it will not (i) make any offer or sale of any Securities, or solicit offers to buy any Securities,
under circumstances that would require the Securities in any Province or Territory of Canada to be
qualified by a prospectus filed in accordance with the securities legislation applicable in such
Province or Territory of Canada, and (ii) engage in any advertisement of the Securities in any
printed media of general and regular paid circulation, radio or any other form of advertising in
connection with the offer and sale of any Securities in such Province or Territory of
Canada.
28
If the foregoing is in accordance with your understanding of our agreement, please sign
and return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall
represent a binding agreement among the Company and the several Underwriters.
Very truly yours, | ||||
U.S. CONCRETE, INC. | ||||
By: | /s/ Xxxxxx X. Xxxxx | |||
Name: | Xxxxxx X. Xxxxx | |||
Title: | Senior Vice President and | |||
Chief Financial Officer |
The foregoing Agreement is
hereby confirmed and accepted
as of the date specified in
Schedule I hereto.
Citigroup Global Markets Inc.
hereby confirmed and accepted
as of the date specified in
Schedule I hereto.
Citigroup Global Markets Inc.
By:
|
/s/ Xxxxx X. Xxxxxxx | |||
Name:
|
Xxxxx X. Xxxxxxx | |||
Title:
|
Managing Director |
For itself and the other
several Underwriters, if any,
named in Schedule II to the
foregoing Agreement.
several Underwriters, if any,
named in Schedule II to the
foregoing Agreement.
SCHEDULE I
Underwriting Agreement dated February 1, 2006
Registration Statement No. 333-42860
Representative(s): Citigroup Global Markets Inc.
Title, Purchase Price and Description of Securities:
Title: Common Stock, par value $0.001 per share
Number of Underwritten Securities to be sold by the Company: 7,000,000
Number of Option Securities to be sold by the Company: 1,050,000
Price per Share to Public (include accrued dividends, if any): $11.250
Price per Share to the Underwriters — total: $10.589
Other provisions:
Closing Date, Time and Location: February 7, 2006 at 10:00 a.m., at Xxxxx Xxxxx L.L.P., 000
Xxxxxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000.
Type of Offering: Non-Delayed
Date referred to in Section 5(h) after which the Company may offer or sell securities issued by the
Company without the consent of the Representative(s): May 2, 2006
SCHEDULE II
Number of Underwritten | ||||
Underwriters | Securities to be Purchased | |||
Citigroup Global Markets Inc. |
4,550,000 | |||
BB&T Capital Markets, a division of Xxxxx & Xxxxxxxxxxxx, Inc. |
1,400,000 | |||
Xxxxxxx Xxxxxx Xxxxxx Inc. |
700,000 | |||
Xxxxxxxxx & Company LLC |
350,000 | |||
Total |
7,000,000 | |||
SCHEDULE III
Schedule of Free Writing Prospectuses included in the Disclosure Package
None.
SCHEDULE IV
Foreign Qualifications of the Company and its subsidiaries
American Concrete Products, Inc.
|
None | |
Atlas-Tuck Concrete, Inc.
|
None | |
B.W.B., Inc. of Michigan
|
Michigan | |
Xxxxx Concrete Enterprises, Ltd.
|
None | |
Xxxxx Industries, Inc.
|
None | |
Xxxxx Investment Corporation, Inc.
|
None | |
Xxxxx Management, Inc.
|
None | |
Builders’ Redi-Mix, LLC
|
Michigan | |
Central Concrete Corp.
|
New Jersey | |
Central Concrete Supply Co., Inc.
|
None | |
Central Precast Concrete, Inc.
|
None | |
Concrete XXXI Acquisition, Inc.
|
None | |
Concrete XXXII Acquisition, Inc.
|
None | |
Concrete XXXIII Acquisition, Inc.
|
None | |
Concrete XXXIV Acquisition, Inc.
|
None | |
Concrete XXXV Acquisition, Inc.
|
None | |
Concrete XXXVI Acquisition, Inc.
|
None | |
Eastern Concrete Materials, Inc.
|
New York | |
Ready Mix Concrete Company of Knoxville
|
Tennessee | |
San Diego Precast Concrete, Inc.
|
California | |
Sierra Precast, Inc.
|
None | |
Xxxxx Pre-cast, Inc.
|
Arizona | |
Superior Concrete Materials, Inc.
|
Virginia, Maryland, Delaware | |
Superior Materials, Inc.
|
None | |
Titan Concrete Industries, Inc.
|
Tennessee, Mississippi | |
U.S. Concrete, Inc.
|
Texas | |
USC GP, Inc.
|
Texas | |
USC LP, Inc.
|
None | |
USC Atlantic, Inc.
|
New Jersey | |
USC Management Co., L.P.
|
None | |
USC Michigan, Inc.
|
Michigan | |
USC Payroll, Inc.
|
Texas | |
U.S. Concrete On-Site, Inc.
|
Maryland, District of Columbia | |
Wyoming Concrete Industries LLC
|
None |
[Form of Lock-Up Agreement] | EXHIBIT A |
[Letterhead of officer or director
of U.S. Concrete, Inc.]
of U.S. Concrete, Inc.]
U.S. Concrete, Inc.
Public Offering of Common Stock
Public Offering of Common Stock
, 2006
Citigroup Global Markets Inc.
As Representative of the several Underwriters,
c/o Citigroup Global Markets Inc.
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
As Representative of the several Underwriters,
c/o Citigroup Global Markets Inc.
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
This letter is being delivered to you in connection with the proposed Underwriting Agreement
(the “Underwriting Agreement”), between U.S. Concrete, Inc., a Delaware corporation (the
“Company”), and you as representative of a group of Underwriters named therein, relating to an
underwritten public offering of Common Stock, $0.001 par value (the “Common Stock”), of the
Company.
In order to induce you and the other Underwriters to enter into the Underwriting Agreement,
the undersigned will not, without the prior written consent of Citigroup Global Markets Inc.,
offer, sell, contract to sell, pledge or otherwise dispose of (or enter into any transaction which
is designed to, or might reasonably be expected to, result in the disposition (whether by actual
disposition or effective economic disposition due to cash settlement or otherwise) by the
undersigned or any affiliate of the undersigned or any person in privity with the undersigned or
any affiliate of the undersigned), directly or indirectly, including the filing (or participation
in the filing) of a registration statement with the Securities and Exchange Commission in respect
of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent
position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and
the rules and regulations of the Securities and Exchange Commission promulgated thereunder with
respect to, any shares of capital stock of the Company or any securities convertible into or
exercisable or exchangeable for such capital stock, or publicly announce an intention to effect any
such transaction, for a period of 90 days after the date of the Underwriting Agreement, other than
(i) any shares of Common Stock disposed of as a bona fide gift or gifts, provided the donee or
donees thereof agree in writing to be bound by the terms of this letter and (ii) any shares of
Common Stock transferred to the Company in connection with netting arrangements associated with tax
withholding requirements applicable to the vesting of shares of restricted stock held by the
undersigned as of the date hereof.
If for any reason the Underwriting Agreement shall be terminated prior to the Closing Date (as
defined in the Underwriting Agreement), the agreement set forth above shall likewise be terminated.
Yours very truly, [Signature of officer or director] [Name and address of officer or director] |
||||